ResMed (NYSE: RMD) and Inspire Medical Systems (NYSE: INSP) are under heavy pressure Monday following Eli Lilly’s (NYSE: LLY) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trader Talk

Oppenheimer Downgrades ResMed (RMD) to PerformJune 25, 2024 6:02 AM Eli Lilly (LLY) PT Raised to $1,000 at Truist SecuritiesJune 24, 2024 4:42 PM ResMed, Inspire Medical slump after Lilly's positive Zepbound data; Citi downgradesJune 24, 2024 9:06 AM